LS patients have the highest levels of CD4+ Vα2.3+ T-cells as well as the best prognosis and are in addition found to have very few extrapulmonary manifestations (EN and ankle arthritis excluded) [24]. This evidence concerns the gene CD4 and Leigh syndrome.